---
figid: PMC2883511__fig-1
figlink: /pmc/articles/PMC2883511/figure/f1/
number: F1
caption: Signaling pathways and targets for LAM. Binding of ligands to cell surface
  receptors such as the insulin receptor and platelet-derived growth factor receptor
  (PDGF) result in phosphorylation of downstream proteins (e.g., IRS 1, PI3K, PDK1
  downstream of IRS 1) and ultimately Akt. The estrogen receptor (ER) can also signal
  through Akt. Akt activates the TSC1/TSC2 complex, which in turn downregulates the
  activity of mTOR, the mammalian target of rapamycin, through an intermediate protein
  called Rheb. In the absence of TSC1 or TSC2, the mTORC1 complex (composed of mTOR
  and raptor and msLT8 (not shown)) is constitutively activated, resulting in inappropriate
  ribosome biogenesis, protein translation, and cell growth (through downstream effectors
  S6K and S6, as well as 4EBP1 and eIF4E), and downregulation of autophagy. mTORC2
  (composed of mTOR, msLT8, and rictor), which controls cytoskeletal arrangement and
  cell movement through downstream effectors ROCK and Rho, is also activated in the
  absence of TSC1 or TSC2. Various steps in this signaling pathway can be blocked
  by currently available agents, including selective estrogen antagonists, tyrosine
  kinase inhibitors, angiogenesis inhibitors, lymphangiogenesis inhibitors, farnesyl
  transferase inhibitors, statins, mTOR inhibitors, metalloproteinase inhibitors,
  and Rho inhibitors.
pmcid: PMC2883511
papertitle: 'Clinical Trials for Rare Lung Diseases: Lessons from Lymphangioleiomyomatosis.'
reftext: Brent Kinder, et al. Lymphat Res Biol. 2010 Mar;8(1):71-79.
pmc_ranked_result_index: '157671'
pathway_score: 0.9349694
filename: fig-1.jpg
figtitle: Signaling pathways and targets for LAM
year: '2010'
organisms: Homo sapiens
ndex: 85dba22e-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2883511__fig-1.html
  '@type': Dataset
  description: Signaling pathways and targets for LAM. Binding of ligands to cell
    surface receptors such as the insulin receptor and platelet-derived growth factor
    receptor (PDGF) result in phosphorylation of downstream proteins (e.g., IRS 1,
    PI3K, PDK1 downstream of IRS 1) and ultimately Akt. The estrogen receptor (ER)
    can also signal through Akt. Akt activates the TSC1/TSC2 complex, which in turn
    downregulates the activity of mTOR, the mammalian target of rapamycin, through
    an intermediate protein called Rheb. In the absence of TSC1 or TSC2, the mTORC1
    complex (composed of mTOR and raptor and msLT8 (not shown)) is constitutively
    activated, resulting in inappropriate ribosome biogenesis, protein translation,
    and cell growth (through downstream effectors S6K and S6, as well as 4EBP1 and
    eIF4E), and downregulation of autophagy. mTORC2 (composed of mTOR, msLT8, and
    rictor), which controls cytoskeletal arrangement and cell movement through downstream
    effectors ROCK and Rho, is also activated in the absence of TSC1 or TSC2. Various
    steps in this signaling pathway can be blocked by currently available agents,
    including selective estrogen antagonists, tyrosine kinase inhibitors, angiogenesis
    inhibitors, lymphangiogenesis inhibitors, farnesyl transferase inhibitors, statins,
    mTOR inhibitors, metalloproteinase inhibitors, and Rho inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - IRS1
  - AKT3
  - EIF4E
  - MTOR
  - PIK3R6
  - MLST8
  - IRS2
  - MAPKAP1
  - PIK3CB
  - PIK3CA
  - FLT4
  - AKT1
  - RICTOR
  - PDGFRA
  - IRS4
  - RPTOR
  - EIF4EBP1
  - PIK3R5
  - AKT2
  - RHEB
  - PIK3R3
  - RHOD
  - PDK1
  - PIK3CG
  - PDGFRB
  - PIK3CD
  - estrogen
  - rapamycin
  - Cancer
genes:
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: mTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: VEGFR3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: mTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: 4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: +(PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals:
- word: estrogen
  source: MESH
  identifier: D004967
- word: rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2883511__F1
redirect_from: /figures/PMC2883511__F1
figtype: Figure
---
